CE-MAT 2025

BDL, RVNL and MDL shares rallied as NSE to add selected stocks in F&O segment

In two different circulars dated May 7 and May 9, the NSE announced the addition of three stocks: Fortis Healthcare, Piramal Pharma, and UNO Minda.

BDL, RVNL and MDL shares rallied as NSE to add selected stocks in F&O segment
Representational Image

Selected PSU Stocks, RVNL, Mazagon Dock and Bharat Dynamics Ltd were trading higher in the Monday’s trading session as NSE issued the circular to add eight stocks in future and options segments from 30th May, 2025.

In two different circulars dated May 7 and May 9, the NSE announced the addition of three stocks: Fortis Healthcare, Piramal Pharma, and UNO Minda. In the second circular, the names of Bharat Dynamics, Kaynes Technology India, Mazagon Dock Shipbuilders, Rail Vikas Nigam, and Mankind Pharma were included.

After the announcement, RVNL's stock jumped 10.25% to Rs 356.70 on Monday, reaching a market valuation of nearly Rs 74,000 crore. With a total mcap of nearly Rs 40,000 crore, Kaynes Technology increased 6% to Rs 6,019.90. Mankind Pharma and Bharat Dynamics both saw 5% increases, reaching Rs 2,526 and Rs 1,607.80, respectively. However, Mazagon Dock forfeited early profits in order to trade in red.

Join PSU Connect on WhatsApp now for quick updates! Whatsapp Channel CE-MAT 2025

Read Also : IREDA Posts Strong Q1 Growth; Disbursements Jump 31%, Loan Book Rises 27%

After the announcement, RVNL's stock jumped 10.25% to Rs 356.70 on Monday, reaching a market valuation of nearly Rs 74,000 crore. With a total mcap of nearly Rs 40,000 crore, Kaynes Technology increased 6% to Rs 6,019.90. Mankind Pharma and Bharat Dynamics both saw 5% increases, reaching Rs 2,526 and Rs 1,607.80, respectively. However, Mazagon Dock forfeited early profits in order to trade in red.

Read Also : NLCIL Thermal Units bag Environment Excellence Gold award-Thermal Sector (2025)

Note*: All the articles and given information on this page are information based and provided by other sources . For more read Terms & Conditions